b.well Connected Health Welcomes Sara Zywicki as New Chief Product Officer

b.well Connected Health, recognized as a leading platform for unified consumer health experiences, announced the appointment of Sara Zywicki as its Chief Product Officer. This pivotal role will see Zywicki spearheading the strategic direction and operational execution of b.well’s innovative product vision, fundamentally enhancing the platform's capacity to foster impactful outcomes for both healthcare organizations and the consumers they serve.

Kristen Valdes, the Founder and CEO of b.well Connected Health, expressed deep confidence in Zywicki's abilities, stating, "Sara brings an unparalleled track record of developing and scaling transformative healthcare technologies across payer, provider, and consumer markets." Valdes emphasized Zywicki's rich expertise in navigating complex regulatory landscapes, launching market-first products, and driving significant growth, all of which sync perfectly with b.well’s ambition to establish a connected health ecosystem that empowers individuals.

Zywicki’s mission includes amplifying b.well’s FHIR-based platform, which is essential in adapting to the evolving demands of their diverse customer base – a mix that includes major health systems, payers, and technology partners. "Healthcare is at a pivotal moment, with the escalating demand for solutions that can tackle fragmentation, complexity, and scalability, " Zywicki commented.

She articulated her enthusiasm about joining b.well at this juncture, asserting that the company's capabilities uniquely position it to lead a healthcare transformation that integrates data, solutions, and services into a consolidated consumer experience. "We enable consumers to navigate their healthcare journey with greater ease and confidence," she emphasized. Her commitment to this cause promises to redefine healthcare delivery and improve consumer experiences significantly.

Zywicki's previous roles reflect her robust background in healthcare technology and digital innovation. Prior to this, she was the Chief Product Officer at OncoHealth, where her efforts resulted in a staggering 600% growth in health plan customers and a 45% annual revenue increase over three years. Notably, she was instrumental in launching Iris™, recognized as the first digital care platform tailored specifically for cancer patients and their caregivers. Furthermore, she played a crucial role in securing subsequent funding that ultimately led to a successful private equity exit in 2022.

Her career also includes significant contributions at SPH Analytics, where she developed a SaaS-based population health platform aimed at optimizing value-based care. Additionally, at Life Line Screening Community Healthcare, Zywicki conceptualized new nationwide healthcare services which generated over $50 million in incremental annual revenue.

About b.well Connected Health

b.well Connected Health is dedicated to addressing and resolving the extensive fragmentation within the healthcare system. With a scalable and dynamic FHIR-based platform, b.well consolidates healthcare data, solutions, and services into an accessible framework. This allows healthcare organizations to deliver experiences where consumers can build longitudinal health records, gain personalized health insights, and conveniently access care services for themselves and their families. By integrating seamlessly into existing digital infrastructures, b.well enhances technology investments and ensures that the consumer remains central to every interaction. To learn more about their groundbreaking initiatives, visit icanbwell.com.